Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2019  |  Volume : 32  |  Issue : 2  |  Page : 465-469

Misoprostol and tranexamic acid role in reducing blood loss during the elective cesarean section


1 Department of Obstetrics and Gynecology, Faculty of Medicine, Menoufia University, Shebeen El-Kom, Egypt
2 Department of Obstetrics and Gynecology, Tala Hospital, Tala City, Egypt

Correspondence Address:
Yehia Z El-Sayd Ghnnam
Tala City 8001, Menoufia Governorate
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/mmj.mmj_916_17

Rights and Permissions

Objective To compare the efficacy of using misoprostol alone or in combination with tranexamic acid (TA) in reducing blood loss during elective cesarean section (CS). Background Normal blood loss during labor is ∼300–400 ml. Blood loss more than 500 ml following vaginal birth or greater than 1000 ml following CS means postpartum hemorrhage. Patients and methods A prospective randomized comparative clinical study was conducted on 150 patients who were divided into two groups: group A (75 patients) received misoprostal 600 mcg rectally before the incision, and group B (75 patients) received misoprostal 600 mcg rectally and 1-g TA slowly intravenously 10 min before the incision. Full medical history, physical examination (general condition and vital signs), prothrombin time, liver and kidney functions, and blood loss volume were recorded. Results Mean age of the studied patients was 28.32 ± 4.65 years in group A and 27.81 ± 5.07 years in group B. Moreover, there was a statistically significant difference between groups regarding hemoglobin postoperatively (P = 0.038), hematocrit postoperatively (P = 0.033), systolic (P = 0.043) and diastolic (P = 0.037) blood pressures 2 h postoperatively, heart rate 2 h postoperatively (P = 0.045), blood loss in the first (P < 0.001) and second periods (P = 0.019), and total blood loss (P < 0.001), with a difference of 146.15 ml (22.6%) less blood loss observed in group B than group A. Conclusion The use of TA before CS is significantly effective in reducing blood loss during cesarean birth, with no observed maternal or neonatal adverse effects (in addition to its low cost). Misoprostol in combination with TA is the most effective treatment in decreasing the amount of blood loss during CS.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed236    
    Printed9    
    Emailed0    
    PDF Downloaded27    
    Comments [Add]    

Recommend this journal